Home › Biogen Inc (BIIB) Rating Increased to Strong-Buy at Vetr Inc.
 

Keywords :   


Biogen Inc (BIIB) Rating Increased to Strong-Buy at Vetr Inc.

2015-12-04 08:27:19| Biotech - Topix.net

The brokerage presently has a $315.11 price target on the biotechnology company's stock. Vetr 's price objective points to a potential upside of 14.38% from the stock's current price.

Tags: inc rating increased biogen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.11tokyobike
16.11Nike Air Jordan 1 MID
16.11M
16.11CAPCOM
16.11XTR M950
16.113DVD
16.11
16.11TECH21 21 FLY RIG 5 V2 SANSAMP
More »